{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:45:24Z","timestamp":1793277924263,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.semarthrit.2015.06.013","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T14:13:00Z","timestamp":1435327980000},"page":"341-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":871,"title":["Colchicine\u2014Update on mechanisms of action and therapeutic uses"],"prefix":"10.1016","volume":"45","author":[{"given":"Ying Ying","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Li","family":"Yao Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia B.","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2015.06.013_bib1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11926-008-0036-3","article-title":"Colchicine: its mechanism of action and efficacy in crystal-induced inflammation","volume":"10","author":"Nuki","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semarthrit.2008.08.006","article-title":"Colchicine update: 2008","volume":"38","author":"Terkeltaub","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/med.20097","article-title":"Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin","volume":"28","author":"Bhattacharyya","year":"2008","journal-title":"Med Res Rev"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/cmdc.201100361","article-title":"The tubulin colchicine domain: a molecular modeling perspective","volume":"7","author":"Massarotti","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib5","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1158\/0008-5472.CAN-13-1778","article-title":"Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment","volume":"74","author":"Charpentier","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib6","doi-asserted-by":"crossref","first-page":"e25332","DOI":"10.1371\/journal.pone.0025332","article-title":"Substance P induces rapid and transient membrane blebbing in U373MG cells in a p21-activated kinase-dependent manner","volume":"6","author":"Meshki","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib7","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1158\/1535-7163.MCT-13-0401","article-title":"Microtubule dynamics control tail retraction in migrating vascular endothelial cells","volume":"12","author":"Ganguly","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib8","doi-asserted-by":"crossref","first-page":"10192","DOI":"10.1158\/0008-5472.CAN-10-2429","article-title":"Free tubulin modulates mitochondrial membrane potential in cancer cells","volume":"70","author":"Maldonado","year":"2010","journal-title":"Cancer Res"},{"issue":"Suppl. 2","key":"10.1016\/j.semarthrit.2015.06.013_bib9","first-page":"S25","article-title":"Polymorphonuclear leukocyte motility in vitro: IV. Colchicine inhibition of chemotactic activity formation after phagocytosis of urate crystals","volume":"58","author":"Phelps","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 2","key":"10.1016\/j.semarthrit.2015.06.013_bib10","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1002\/art.23069","article-title":"Urate crystals, inflammation, and colchicine","volume":"58","author":"McCarty","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib11","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/art.11079","article-title":"Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis","volume":"48","author":"Ryckman","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib12","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/ar4250","article-title":"Modulation of monosodium urate crystal-induced responses in neutrophils by the myeloid inhibitory C-type lectin-like receptor: potential therapeutic implications","volume":"15","author":"Gagn\u00e9","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00917514","article-title":"Colchicine and methotrexate reduce leukocyte adherence and emigration in rat mesenteric venules","volume":"16","author":"Asako","year":"1992","journal-title":"Inflammation"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib14","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib15","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1172\/JCI116759","article-title":"Crystal-induced neutrophil activation. IV. Specific inhibition of tyrosine phosphorylation by colchicine","volume":"92","author":"Roberge","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib16","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/art.23801","article-title":"Crystal-induced neutrophil activation: X. Proinflammatory role of the tyrosine kinase Tec","volume":"58","author":"Popa-Nita","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib17","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1189\/jlb.1012510","article-title":"Technical advance: inhibition of neutrophil chemotaxis by colchicine is modulated through viscoelastic properties of subcellular compartments","volume":"94","author":"Paschke","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib18","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/bjp.2008.20","article-title":"Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine","volume":"153","author":"Chia","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00232-011-9404-4","article-title":"Colchicine modulates oxidative stress in serum and neutrophil of patients with Beh\u00e7et disease through regulation of Ca\u00b2+ release and antioxidant system","volume":"244","author":"Korkmaz","year":"2011","journal-title":"J Membr Biol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ni.2550","article-title":"Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome","volume":"14","author":"Misawa","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib22","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1002\/jcb.24231","article-title":"The effect of colchicine on pyrin and pyrin interacting proteins","volume":"113","author":"Taskiran","year":"2012","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib23","doi-asserted-by":"crossref","first-page":"11378","DOI":"10.1074\/jbc.M112.448795","article-title":"Ribotoxic stress through p38 mitogen-activated protein kinase activates in vitro the human pyrin inflammasome","volume":"288","author":"Yu","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/RHU.0b013e31827d8790","article-title":"Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis","volume":"19","author":"Cronstein","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.40.6.605","article-title":"Prolonged reduction in polymorphonuclear adhesion following oral colchicine","volume":"40","author":"Fordham","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib26","first-page":"600","article-title":"Treatment with colchicine decreases white cell counts in synovial fluid of asymptomatic knees that contain monosodium urate crystals","volume":"19","author":"Pascual","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib27","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1182\/blood-2008-01-134932","article-title":"The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-\u03baB through its N-terminal fragment","volume":"112","author":"Chae","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10517-011-1415-8","article-title":"Albendazole and colchicine modulate LPS-induced secretion of inflammatory mediators by liver macrophages","volume":"151","author":"Viktorov","year":"2011","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib29","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.4049\/jimmunol.180.12.7827","article-title":"Lysophospholipids and ATP mutually suppress maturation and release of IL-1 beta in mouse microglial cells using a Rho-dependent pathway","volume":"180","author":"Takenouchi","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib30","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1476-5381.2011.01254.x","article-title":"Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action","volume":"163","author":"Marques-da-Silva","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib31","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib32","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1476-5381.2011.01325.x","article-title":"Many ways to dilate the P2X7 receptor pore","volume":"163","author":"Pelegr\u00edn","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib33","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood-2005-03-1161","article-title":"Discovery of novel immunostimulants by dendritic-cell-based functional screening","volume":"106","author":"Mizumoto","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib34","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/sj.jid.5700699","article-title":"Colchicine promotes antigen cross-presentation by murine dendritic cells","volume":"127","author":"Mizumoto","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/CJI.0b013e3181cd1094","article-title":"Chemotherapeutic agents targeting the tubulin cytoskeleton modify LPS-induced cytokine secretion by dendritic cells and increase antigen presentation","volume":"33","author":"Marin-Esteban","year":"2010","journal-title":"J Immunother"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.imlet.2004.05.013","article-title":"Functional microtubules are required for antigen processing by macrophages and dendritic cells","volume":"95","author":"Peachman","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib37","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1067\/mlc.2002.124397","article-title":"Colchicine decreases apoptotic cell death in chronic cyclosporine nephrotoxicity","volume":"139","author":"Li","year":"2002","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib38","doi-asserted-by":"crossref","first-page":"F1466","DOI":"10.1152\/ajprenal.00057.2013","article-title":"Colchicine attenuates renal injury in a model of hypertensive chronic kidney disease","volume":"305","author":"Guan","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11418-009-0347-3","article-title":"Curcumin prevents liver fibrosis by inducing apoptosis and suppressing activation of hepatic stellate cells","volume":"63","author":"Shu","year":"2009","journal-title":"J Nat Med"},{"issue":"Suppl. 5","key":"10.1016\/j.semarthrit.2015.06.013_bib40","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1177\/089686080802805S11","article-title":"The effects of colchicine on the progression and regression of encapsulating peritoneal sclerosis","volume":"28","author":"Bozkurt","year":"2008","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib41","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1074\/jbc.M113.464461","article-title":"Control of myofibroblast differentiation by microtubule dynamics through a regulated localization of mDia2","volume":"288","author":"Sandbo","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib42","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ejim.2012.04.007","article-title":"Mean platelet volume and \u03b2-thromboglobulin levels in familial Mediterranean fever: effect of colchicine use?","volume":"23","author":"Abanonu","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib43","first-page":"2024","article-title":"Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?","volume":"35","author":"Terekeci","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jss.2007.04.029","article-title":"Colchicine inhibits intimal hyperplasia and leukocyte VEGF expression in dogs","volume":"146","author":"Atta","year":"2008","journal-title":"J Surg Res"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib45","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejps.2013.08.004","article-title":"Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension","volume":"50","author":"Lee","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-511X-13-67","article-title":"Synergistic effects of colchicine combined with atorvastatin in rats with hyperlipidemia","volume":"13","author":"Huang","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib47","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib48","unstructured":"U.S. Food and Drug Administration. Online, \u3008http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm174315.htm\u3009. Accessed 20.12.13."},{"key":"10.1016\/j.semarthrit.2015.06.013_bib49","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/art.30389","article-title":"Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors","volume":"63","author":"Terkeltaub","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib50","unstructured":"National Center for Biotechnology Information. Online, \u3008http:\/\/www.ncbi.nlm.nih.gov\/SNP\/snp_ref.cgi?chooseRs=coding&locusId=5243&mrna\u3009. Accessed 20.12.14."},{"key":"10.1016\/j.semarthrit.2015.06.013_bib51","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3109\/0886022X.2011.605980","article-title":"Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients","volume":"33","author":"Ozen","year":"2011","journal-title":"Ren Fail"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib52","first-page":"1540","article-title":"Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever","volume":"34","author":"Tufan","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/gtmb.2013.0293","article-title":"Relationship between response to colchicine treatment and MDR1 polymorphism in familial Mediterranean fever patients","volume":"18","author":"Uludag","year":"2014","journal-title":"Genet Tes Mol Biomarkers"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.gene.2012.05.040","article-title":"MDR1 gene polymorphisms may be associated with Beh\u00e7et\u02bcs disease and its colchicum treatment response","volume":"505","author":"Rustemoglu","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib55","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.4238\/2013.January.24.2","article-title":"Lack of an effect of CYP3A4 and MDR1 gene polymorphisms on colchicine pharmacogenetics in the treatment of Familial Mediterranean fever","volume":"12","author":"Dogruer","year":"2013","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4238\/vol10-1gmr824","article-title":"Investigation of ABCB1 gene polymorphism with colchicine response in Beh\u00e7et\u02bcs disease","volume":"10","author":"Saricaoglu","year":"2011","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib57","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"6 Suppl. 1","key":"10.1016\/j.semarthrit.2015.06.013_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3810\/pgm.2011.11.2511","article-title":"2011 Recommendations for the diagnosis and management of gout and hyperuricemia","volume":"123","author":"Hamburger","year":"2011","journal-title":"Postgrad Med"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib59","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.clinthera.2011.01.008","article-title":"Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials","volume":"32","author":"Wortmann","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib60","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis","volume":"31","author":"Borstad","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib61","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/ard.34.5.379","article-title":"New Haven survey of joint diseases. XVII. Relationship between some systemic characteristics and osteoarthrosis in a general population","volume":"34","author":"Acheson","year":"1975","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib62","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/030097400447589","article-title":"Serum uric acid and patterns of radiographic osteoarthritis\u2014the Ulm Osteoarthritis Study","volume":"29","author":"Sun","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib63","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/ard.2006.063768","article-title":"Are joints affected by gout also affected by osteoarthritis?","volume":"66","author":"Roddy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib64","first-page":"1108","article-title":"Association between crystals and cartilage degeneration in the ankle","volume":"35","author":"Muehleman","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib65","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.3899\/jrheum.130708","article-title":"The effects of monosodium urate monohydrate crystals on chondrocyte viability and function: implications for development of cartilage damage in gout","volume":"40","author":"Chhana","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib66","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1073\/pnas.1012743108","article-title":"Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation","volume":"108","author":"Denoble","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib67","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/joca.2002.0516","article-title":"A randomized controlled trial to evaluate the slow-acting symptom modifying effects of a regimen containing colchicine in a subset of patients with osteoarthritis of the knee","volume":"10","author":"Das","year":"2002","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib68","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/art.10455","article-title":"A randomized controlled trial to evaluate the slow-acting symptom-modifying effects of colchicine in osteoarthritis of the knee: a preliminary report","volume":"47","author":"Das","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib69","first-page":"513","article-title":"A double-blind randomized controlled trial appraising the symptom-modifying effects of colchicine on osteoarthritis of the knee","volume":"29","author":"Aran","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib70","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13063-015-0726-x","article-title":"Colchicine effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): study protocol for a randomized controlled trial","volume":"16","author":"Leung","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib71","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/09273948.2012.665124","article-title":"Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Beh\u00e7et\u02bcs disease","volume":"20","author":"Takeuchi","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib72","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/s10165-009-0200-2","article-title":"Colchicine versus placebo in Beh\u00e7et\u02bcs disease: randomized, double-blind, controlled crossover trial","volume":"19","author":"Davatchi","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib73","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1600-0714.2009.00774.x","article-title":"Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-alpha level in patients with mucocutaneous type of Behcet\u02bcs disease","volume":"38","author":"Sun","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib74","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/eci.12170","article-title":"Familial Mediterranean fever: a fascinating model of inherited autoinflammatory disorder","volume":"43","author":"Portincasa","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib75","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJM197410312911804","article-title":"Colchicine therapy for familial Mediterranean fever. A double-blind trial","volume":"291","author":"Dinarello","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib76","first-page":"431","article-title":"Familial Mediterranean fever (FMF) and renal AA amyloidosis\u2014phenotype-genotype correlation, treatment and prognosis","volume":"16","author":"Ben-Chetrit","year":"2003","journal-title":"J Nephrol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib77","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1542\/peds.2006-1434","article-title":"Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement","volume":"119","author":"Kallinich","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib78","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/archinte.165.17.1987","article-title":"Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial","volume":"165","author":"Imazio","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib79","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","article-title":"Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial","volume":"112","author":"Imazio","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib80","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","article-title":"Colchicine for recurrent pericarditis (CORP): a randomized trial","volume":"155","author":"Imazio","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib81","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicenter, double-blind, placebo-controlled, randomized trial","volume":"383","author":"Imazio","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib82","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","article-title":"A randomized trial of colchicine for acute pericarditis","volume":"369","author":"Imazio","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib83","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1093\/eurheartj\/ehq319","article-title":"COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicenter, randomized, double-blind, placebo-controlled trial","volume":"31","author":"Imazio","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib84","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ahj.2013.03.025","volume":"166","author":"Imazio","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib85","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1345\/aph.1M234","article-title":"Colchicine for the primary and secondary prevention of pericarditis: an update","volume":"43","author":"Kuo","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib86","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/heartjnl-2011-301306","article-title":"Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta-analysis","volume":"98","author":"Imazio","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib87","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.amjcard.2011.03.087","article-title":"Meta-analysis of randomized trials focusing on prevention of the postpericardiotomy syndrome","volume":"108","author":"Imazio","year":"2011","journal-title":"Am J Cardio"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib88","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ahj.2010.06.015","article-title":"International collaborative systematic review of controlled clinical trials on pharmacological treatments for acute pericarditis and its recurrences","volume":"160","author":"Lotrionte","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib89","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijcard.2012.06.040","article-title":"Impact of Colchicine on pericardial inflammatory syndromes\u2014an analysis of randomized controlled trials","volume":"161","author":"Alam","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib90","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ehj.2004.02.002","article-title":"Guidelines on the diagnosis and management of pericardial diseases executive summary; the Task force on the diagnosis and management of pericardial diseases of the European society of cardiology","volume":"25","author":"Maisch","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib91","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib92","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jacc.2013.01.055","article-title":"Colchicine treatment for the prevention of bare metal stent restenosis in diabetic patients","volume":"61","author":"Deftereos","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib93","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11239-011-0637-y","article-title":"Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial","volume":"33","author":"Raju","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib94","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jchf.2013.11.006","article-title":"Anti-Inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study","volume":"2","author":"Deftereos","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib95","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/j.gastro.2005.01.057","article-title":"Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival","volume":"128","author":"Morgan","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib96","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM198806303182602","article-title":"Colchicine in the treatment of cirrhosis of the liver","volume":"318","author":"Kershenobich","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib97","first-page":"CD002148","article-title":"Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis","volume":"18","author":"Rambaldi","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib98","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.3748\/wjg.v16.i23.2889","article-title":"Colchicine reduces procollagen III and increases pseudocholinesterase in chronic liver disease","volume":"16","author":"Muntoni","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib99","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s10620-010-1291-5","article-title":"Methotrexatein patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid","volume":"55","author":"Kaplan","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib100","first-page":"1365","article-title":"Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases","volume":"129","author":"Fontes","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib101","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.25011\/cim.v33i3.13725","article-title":"Comparison of colchicine versus prednisolone in recurrent aphthous stomatitis: a double-blind randomized clinical trial","volume":"33","author":"Pakfetrat","year":"2010","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib102","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/09546630701499309","article-title":"Urticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic features","volume":"19","author":"Criado","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib103","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2133.1989.tb04167.x","article-title":"Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine","volume":"120","author":"Lawlor","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib104","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000332846","article-title":"The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativa","volume":"223","author":"van der Zee","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.ijir.3901185","article-title":"Therapeutic effects of colchicine in the management of Peyronie\u02bcs disease: a randomized double-blind, placebo-controlled study","volume":"16","author":"Safarinejad","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.semarthrit.2015.06.013_bib106","first-page":"105","article-title":"Colchicine, cyclophosphamide and prednisone in the treatment of mild-moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens","volume":"12","author":"Fiorucci","year":"2008","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215001791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215001791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T08:51:29Z","timestamp":1620809489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017215001791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0049017215001791"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.013","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colchicine\u2014Update on mechanisms of action and therapeutic uses","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}